|
| Press Releases |
|
 |
|
| Thursday, March 30, 2023 |
|
|
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq |
| Apollomics Inc. ("Apollomics" or the "Company"), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced the completion of its business combination (the "Business Combination") with Maxpro Capital Acquisition Corp. ("Maxpro", Nasdaq: JMAC). more info >> |
|
| Tuesday, July 26, 2022 |
|
|
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer |
| Apollomics Inc. an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced the appointment of Jane Wang, PhD as Chief Scientific Officer. In this role, Dr. Wang will lead the drug discovery pipeline for the Company. She will also serve as Apollomics' China General Manager and will report to the Chief Executive Officer. more info >> |
|
| Wednesday, January 12, 2022 |
|
|
Apollomics Inc. to Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday, January 27, 2022 |
| Apollomics Inc. an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the management team will host two upcoming webcasts to accommodate participants from the U.S. and China. more info >> |
|
| Tuesday, January 4, 2022 |
|
|
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group |
| Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer of Apollomics, was recently appointed to Chairman of the Board for the BayHelix Group, effective January 2022. more info >> |
|
| Monday, November 22, 2021 |
|
|
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia |
| Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the first patient has been successfully dosed in a Phase 3 clinical trial of APL-106 (uproleselan injection) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) in China. more info >> |
|
| Friday, October 1, 2021 |
|
|
Edison Oncology and Apollomics Announce Treatment of First Patient by EO1001 (APL-122) in a Phase I/IIa Clinical Trial |
| Edison Oncology Holding Corp. ('Edison Oncology'), a company established to develop new therapies targeting the fight against cancer, and Apollomics Inc. ('Apollomics'), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, reported that the first patient was dosed with EO1001 (APL-122) in a Phase I/IIa clinical trial in patients with advanced solid tumors. more info >> |
|
| Tuesday, August 10, 2021 |
|
|
Apollomics, Inc. Doses First Patient in a Phase I Clinical Trial of APL-102 |
| Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, today announced the successful dosing of the first patient in a Phase I clinical study of APL-102 in patients with advanced solid tumors. more info >> |
|
| Thursday, May 20, 2021 |
|
|
APOLLOMICS INC. ANNOUNCES OFFICIAL OPENING OF SHANGHAI BRANCH |
| Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Apollomics Shanghai Branch has been officially opened and started its operations at Zhangjiang Hi-Tech Park, Pudong District, Shanghai. more info >> |
|
| Tuesday, March 9, 2021 |
|
|
Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer |
| Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced the appointment of K. Peony Yu, M.D. as Chief Medical Officer. Dr. Yu will assume the role on March 16, 2021. more info >> |
|
| Thursday, March 4, 2021 |
|
|
Apollomics, Inc Announces Enrollment of First Patient in Phase 1 Clinical Trial of APL-106 (uproleselan injection) in China |
| Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the first patient has been successfully enrolled into a Phase 1 clinical trial of APL-106 (uproleselan injection) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) in China. In February of this year, the two Phase 1 study sites were initiated. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Former Premier of Queensland Takes Over Reins of Australian Battery Industry Association (AMBC) Cofounded by GMG's Managing Director
Oct 13, 2025 20:59 HKT/SGT
|
|
|
45th Autumn Electronics Fair and electronicAsia open today
Oct 13, 2025 20:14 HKT/SGT
|
|
|
Patriot Critical Minerals Confirms Largest Tungsten Resource in the United States with Filing of SEC S-K 1300 Technical Report
Oct 13, 2025 20:09 HKT/SGT
|
|
|
Kangji Medical and Knight Bidco Jointly Dispatch Scheme Document for Privatisation Proposal
Oct 13, 2025 10:14 HKT/SGT
|
|
|
Open Dialogue Project Launches 2026 International Essay Contest on Global Development 
Oct 11, 2025 17:00 HKT/SGT
|
|
|
After Beijing, Shoucheng Holdings Opens Robot Experience Store in Chengdu's Core Business District, National Rollout Begins as Consumer-Facing Scenarios Accelerate
Oct 11, 2025 09:58 HKT/SGT
|
|
|
Scandium International Mining Announces Grant of New Mining Lease at Nyngan Scandium Project
Oct 11, 2025 02:29 HKT/SGT
|
|
|
Hitachi Advances Strategic Alliance with Google Cloud to Empower Frontline Workers with Field-Specific AI Agents
Oct 10, 2025 0:58 JST
|
|
|
Honda Issues Integrated Report - "Honda Report 2025"
Oct 10, 2025 0:46 JST
|
|
|
DENSO's Electrification Products Adopted for TOYOTA's New "bZ4X"
Oct 10, 2025 0:21 JST
|
|
|
Newly developed eAxle adopted for TOYOTA's new "bZ4X"
Oct 10, 2025 0:08 JST
|
|
|
MHIET and MHI-TC Complete Delivery of First "COORDY" Controller Providing Optimized Control of Multiple Power Sources
Oct 10, 2025 23:47 JST
|
|
|
Fujitsu migrates service operations virtualization platform used by 3,000 companies to Nutanix and introduces migration support services utilizing proven expertise
Oct 10, 2025 23:25 JST
|
|
|
Shares of Golden Leaf International Group Limited Commence Trading on GEM of HKEX Today
Oct 10, 2025 19:10 HKT/SGT
|
|
|
TripGift(R) Unlocks Glocal Bucket List' Dreams With Launch of New Destination Gift Card SKUs and Marketplaces for Cities, Destinations and Experiences
Oct 10, 2025 15:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
